Please assess the completion status of the following clinical trial:

Trial Title: Customized Medication Adherence Enhancement for Treating Adults With Bipolar Disorder

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of bipolar disorder (BPD) Type I or Type II, as determined by a standardized diagnostic interview, the Mini-International Neuropsychiatric Interview (MINI)~* Demonstrated history of poor medication adherence, as determined by self-report or clinician report. In this study, self-reported treatment nonadherence will be identified with the Tablet Routines Questionnaire (TRQ). Poorly adherent individuals will be defined as those who miss 30% or more of medication within either the past week or past month (those missing 30% or more within past week will be considered to be nonadherent over the past month). Clinician-assessed nonadherence will be identified via a clinician version of the TRQ to identify nonadherence of 30% or more over the past 30 days.~* BPD of at least 2 years' duration~* Treatment with medication to stabilize mood for at least 6 months~Exclusion Criteria:~* Unable/unwilling to participate in psychiatric interviews, as based on the clinical opinion of the investigator or the treating clinician~* High risk of suicide, as seen in factors such as active suicidal ideation, recent suicide attempt, or current intent or plan~* Inability to speak English~* Individuals who have participated in Project 1, Personal Adherence Evaluation of Individuals Receiving Treatment for Bipolar Disorder (PAE in BD)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Customized Adherence Enhancement (CAE) (Type: EXPERIMENTAL): Participants, all of whom have a history of medication nonadherence, will be assigned to one or more treatment modules based on their individual profiles.~Treatment Modules:~Psychoeducation module Substance abuse module Improved communication/rapport with provider module Medication routines management module

Based on this trial design, predict the completion outcome and termination type (if applicable).